Clinical Microbiology Reviews

Papers
(The TQCC of Clinical Microbiology Reviews is 35. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Editorial Board289
Editorial Board259
Editorial Board164
2022 Acknowledgment of CMR Reviewers151
Diagnosis, Management, and Future Control of Cholera146
Therapeutics for Vancomycin-Resistant Enterococcal Bloodstream Infections123
Extracutaneous sporotrichosis122
Companions in antimicrobial resistance: examining transmission of common antimicrobial-resistant organisms between people and their dogs, cats, and horses117
Streptococcus dysgalactiae subsp. equisimilis infection and its intersection with Streptococcus pyogenes108
Beyond schistosomiasis: unraveling co-infections and altered immunity99
Worldwide Control and Management of Chagas Disease in a New Era of Globalization: a Close Look at Congenital Trypanosoma cruzi Infection98
BCG therapy in bladder cancer and its tumor microenvironment interactions88
Candidate Phyla Radiation, an Underappreciated Division of the Human Microbiome, and Its Impact on Health and Disease81
SARS-CoV-2 Antiviral Therapy79
Transmission of Infections during Cardiopulmonary Resuscitation79
2024 Acknowledgment of CMR Reviewers74
Recent advances in the influenza virus vaccine landscape: a comprehensive overview of technologies and trials73
Wastewater-based surveillance as a tool for public health action: SARS-CoV-2 and beyond72
Natural-Product-Based Solutions for Tropical Infectious Diseases67
Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal disease66
Recent development and fighting strategies for lincosamide antibiotic resistance62
Updated Review onNocardiaSpecies: 2006–202160
Practical Guidance for Clinical Microbiology Laboratories: Diagnosis of Ocular Infections58
Wild-type distributions of minimum inhibitory concentrations and epidemiological cut-off values—laboratory and clinical utility52
Monkeypox Virus Infections in Humans51
Klebsiella oxytoca Complex: Update on Taxonomy, Antimicrobial Resistance, and Virulence48
Osteoarticular Mycoses47
Human and Animal Fascioliasis: Origins and Worldwide Evolving Scenario46
A Comprehensive Review on the Role of the Gut Microbiome in Human Neurological Disorders44
Antiviral Approaches against Influenza Virus44
Vaccines and monoclonal antibodies to prevent healthcare-associated bacterial infections43
Toward better cures for Mycobacterium abscessus lung disease43
Rapid and accurate testing for urinary tract infection: new clothes for the emperor41
Invasive fusariosis41
Laboratory detection of carbapenemases among Gram-negative organisms40
The potential for development of clinically relevant microbial resistance to rifaximin-α: a narrative review39
Intestinal Bacteriophage Therapy: Looking for Optimal Efficacy39
Mesenchymal Stromal Cells: an Antimicrobial and Host-Directed Therapy for Complex Infectious Diseases38
Clinical Microbiology Reviews : a 21st century vision37
Staphylococcus capitis : insights into epidemiology, virulence, and antimicrobial resistance of a clinically relevant bacterial species37
COVID-19 Convalescent Plasma and Clinical Trials: Understanding Conflicting Outcomes35
Evolving mechanisms and presentations of cardiovascular disease in people with HIV: implications for management35
0.036950826644897